89 related articles for article (PubMed ID: 9718012)
1. Clinical significance of clonality in thyroid nodules.
Kim H; Piao Z; Park C; Chung WY; Park CS
Br J Surg; 1998 Aug; 85(8):1125-8. PubMed ID: 9718012
[TBL] [Abstract][Full Text] [Related]
2. Clonal analysis of a solitary follicular nodule of the thyroid with the polymerase chain reaction method.
Chung DH; Kang GH; Kim WH; Ro JY
Mod Pathol; 1999 Mar; 12(3):265-71. PubMed ID: 10102611
[TBL] [Abstract][Full Text] [Related]
3. Clonal X-inactivation analysis of human tumours using the human androgen receptor gene (HUMARA) polymorphism: a non-radioactive and semiquantitative strategy applicable to fresh and archival tissue.
Kopp P; Jaggi R; Tobler A; Borisch B; Oestreicher M; Sabacan L; Jameson JL; Fey MF
Mol Cell Probes; 1997 Jun; 11(3):217-28. PubMed ID: 9232621
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
[TBL] [Abstract][Full Text] [Related]
5. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
6. A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression.
Rosen J; He M; Umbricht C; Alexander HR; Dackiw AP; Zeiger MA; Libutti SK
Surgery; 2005 Dec; 138(6):1050-6; discussion 1056-7. PubMed ID: 16360390
[TBL] [Abstract][Full Text] [Related]
7. Fine-needle aspiration biopsy-RT-PCR expression analysis of prothymosin alpha and parathymosin in thyroid: novel proliferation markers?
Letsas KP; Vartholomatos G; Tsepi C; Tsatsoulis A; Frangou-Lazaridis M
Neoplasma; 2007; 54(1):57-62. PubMed ID: 17203893
[TBL] [Abstract][Full Text] [Related]
8. Clonal origin of non-medullary thyroid tumours assessed by non-random X-chromosome inactivation.
Moniz S; Catarino AL; Marques AR; Cavaco B; Sobrinho L; Leite V
Eur J Endocrinol; 2002 Jan; 146(1):27-33. PubMed ID: 11751063
[TBL] [Abstract][Full Text] [Related]
9. [Detection of malignancy markers in thyroid nodules by reverse transcriptase polymerase chain reaction (RT-PCR)].
Pineda P; Rojas P; Liberman C; Moyano L; Goecke I
Rev Med Chil; 2003 Sep; 131(9):965-72. PubMed ID: 14635582
[TBL] [Abstract][Full Text] [Related]
10. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
11. Clonal analysis of focal nodular hyperplasia of the liver.
Gaffey MJ; Iezzoni JC; Weiss LM
Am J Pathol; 1996 Apr; 148(4):1089-96. PubMed ID: 8644851
[TBL] [Abstract][Full Text] [Related]
12. Molecular evidence that the stromal and epithelial cells in pleomorphic adenomas of salivary gland arise from the same origin: clonal analysis using human androgen receptor gene (HUMARA) assay.
Lee PS; Sabbath-Solitare M; Redondo TC; Ongcapin EH
Hum Pathol; 2000 Apr; 31(4):498-503. PubMed ID: 10821498
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of the insulin-like growth factor I gene promoter (P1) polymorphism in thyroid nodular disease.
Wasko R; Michalek K; Pacholska J; Obrepalska-Steplowska A; Gozdzicka-Jozefiak A; Sowinski J
Neuro Endocrinol Lett; 2005 Dec; 26(6):699-703. PubMed ID: 16380677
[TBL] [Abstract][Full Text] [Related]
14. Clonality analysis of intraductal proliferative lesions using the human androgen receptor assay.
Li H; Chen Q; Zhu R; Gu DH; Zhu HG
Neoplasma; 2007; 54(6):490-4. PubMed ID: 17949232
[TBL] [Abstract][Full Text] [Related]
15. The C allele of the GNB3 C825T polymorphism of the G protein beta3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours.
Sheu SY; Handke S; Bröcker-Preuss M; Görges R; Frey UH; Ensinger C; Ofner D; Farid NR; Siffert W; Schmid KW
J Pathol; 2007 Jan; 211(1):60-6. PubMed ID: 17136758
[TBL] [Abstract][Full Text] [Related]
16. Molecular aspects of the pathogenesis of nodular goiters, thyroid nodules and adenomas.
Derwahl M
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():32-5. PubMed ID: 8980997
[TBL] [Abstract][Full Text] [Related]
17. Different genotype distribution of the GNB3 C825T polymorphism of the G protein beta3 subunit in adenomas and differentiated thyroid carcinomas of follicular cell origin.
Sheu SY; Görges R; Ensinger C; Ofner D; Farid NR; Siffert W; Schmid KW
J Pathol; 2005 Dec; 207(4):430-5. PubMed ID: 16178055
[TBL] [Abstract][Full Text] [Related]
18. Ras mutations are rare in solitary cold and toxic thyroid nodules.
Krohn K; Reske A; Ackermann F; Müller A; Paschke R
Clin Endocrinol (Oxf); 2001 Aug; 55(2):241-8. PubMed ID: 11531932
[TBL] [Abstract][Full Text] [Related]
19. Solitary thyroid nodule: current management.
Delbridge L
ANZ J Surg; 2006 May; 76(5):381-6. PubMed ID: 16768700
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules.
Aratake Y; Umeki K; Kiyoyama K; Hinoura Y; Sato S; Ohno A; Kuribayashi T; Hirai K; Nabeshima K; Kotani T
Diagn Cytopathol; 2002 Jun; 26(6):366-72. PubMed ID: 12112826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
